Results 261 to 270 of about 2,246,984 (309)
Some of the next articles are maybe not open access.
PET Imaging of Atherosclerosis
Future Cardiology, 2015Atherosclerosis is a chronic, progressive, multifocal disease of the arterial wall, which is mainly fuelled by local and systemic inflammation, often resulting in acute ischemic events following plaque rupture and vessel occlusion. When assessing the cardiovascular risk of an individual patient, we must consider both global measures of disease activity
Jason M, Tarkin +3 more
openaire +2 more sources
2021
Yttrium-86 is a non-standard positron emitter that can provide dosimetry information prior to therapy with yttrium-90 radiopharmaceuticals and be used to follow biochemical processes. In this chapter, we discuss the production, purification and applications of 86Y for PET imaging.
Mariane, Le Fur, Peter, Caravan
openaire +2 more sources
Yttrium-86 is a non-standard positron emitter that can provide dosimetry information prior to therapy with yttrium-90 radiopharmaceuticals and be used to follow biochemical processes. In this chapter, we discuss the production, purification and applications of 86Y for PET imaging.
Mariane, Le Fur, Peter, Caravan
openaire +2 more sources
PET Imaging of Pheochromocytoma
PET Clinics, 2007Pheochromocytomas are tumors derived from chromaffin cells of the adrenal medulla that synthesize, store, metabolize, and usually, but not always, secrete catecholamines. Although pheochromocytomas are the cause of hypertension in only a small number of patients, they can precipitate life-threatening hypertension or cardiac arrhythmias caused by ...
Sameer, Khan +6 more
openaire +2 more sources
Orthopedic Clinics of North America, 2015
PET imaging has been evaluated in five areas of sarcoma diagnosis and treatment: biopsy guidance, therapeutic monitoring, tumor detection and grading, tumor staging, and prognostication. Current evidence does not include any cost-benefit analysis showing a decreased number of invasive procedures from false-positive results.
Stephen, Becher, Shervin, Oskouei
openaire +2 more sources
PET imaging has been evaluated in five areas of sarcoma diagnosis and treatment: biopsy guidance, therapeutic monitoring, tumor detection and grading, tumor staging, and prognostication. Current evidence does not include any cost-benefit analysis showing a decreased number of invasive procedures from false-positive results.
Stephen, Becher, Shervin, Oskouei
openaire +2 more sources
Radiologic Clinics of North America, 2004
In 1973, Godfrey Hounsfield introduced radiographic CT, which truly revolutionized the field of radiology. Later that year, the concept of [F]fluorodeoxyglucose PET (FDG-PET) was born when three investigators from the University of Pennsylvania (Penn)—Martin Reivich, David Kuhl, and myself—discussed the feasibility of labeling deoxyglucose (DG) with a ...
openaire +2 more sources
In 1973, Godfrey Hounsfield introduced radiographic CT, which truly revolutionized the field of radiology. Later that year, the concept of [F]fluorodeoxyglucose PET (FDG-PET) was born when three investigators from the University of Pennsylvania (Penn)—Martin Reivich, David Kuhl, and myself—discussed the feasibility of labeling deoxyglucose (DG) with a ...
openaire +2 more sources
PET imaging for cancer immunotherapy: the Immuno-PET
Annals of Oncology, 2022Abstract Checkpoint immunotherapy has revolutionised medicine, and is now a cornerstone treatment for the majority of cancer types. Despite intense efforts to identify biomarkers of response, predominantly focused on tumour biopsies taken prior to treatment, none are sufficiently robust to direct treatment, in part due to inter-tumoural heterogeneity.
A M, Menzies, S, Lastoria
openaire +2 more sources
Applications of Small Animal Imaging with PET, PET/CT, and PET/MR Imaging
PET Clinics, 2008Small animal techniques of PET, MR imaging, and CT are most frequently applied in preclinical oncology research, but cardiovascular and neurologic research protocols can also take advantage of these innovative approaches. PET is used to provide functional information about disease activity.
Cristina, Nanni, Drew A, Torigian
openaire +2 more sources
Neuroimaging Clinics of North America
Following a brief review of brain neurofluid pathways and the general PET technique, we introduce PET imaging of cerebrospinal fluid and interstitial fluid dynamics. Our summary includes both our published and unpublished observations on the modeling of PET imaging for neurofluid quantification in aging, Alzheimer's disease, and in the presence of ...
Liangdong, Zhou, Yi, Li, Mony J, de Leon
openaire +3 more sources
Following a brief review of brain neurofluid pathways and the general PET technique, we introduce PET imaging of cerebrospinal fluid and interstitial fluid dynamics. Our summary includes both our published and unpublished observations on the modeling of PET imaging for neurofluid quantification in aging, Alzheimer's disease, and in the presence of ...
Liangdong, Zhou, Yi, Li, Mony J, de Leon
openaire +3 more sources
Expert Review of Hematology, 2009
PET has become a cornerstone procedure in modern lymphoma management. This paper reviews, from a clinical point of view, the evidence for using PET in the different subtypes of lymphoma and the different steps of their management. The reader is given an overview of the current PET-based interventional lymphoma trials and an insight into possible future
openaire +2 more sources
PET has become a cornerstone procedure in modern lymphoma management. This paper reviews, from a clinical point of view, the evidence for using PET in the different subtypes of lymphoma and the different steps of their management. The reader is given an overview of the current PET-based interventional lymphoma trials and an insight into possible future
openaire +2 more sources
FDG-PET and amyloid-PET imaging
Current Opinion in Neurology, 2014The availability of PET neuroimaging tools for the in-vivo assessment of metabolic dysfunction and amyloid burden in Alzheimer's disease has opened important methodological and practical issues in the diagnostic design and the conduct of new clinical trials.
openaire +4 more sources